Trials / Completed
CompletedNCT04569188
Convalescent Plasma in COVID-19 Elderly Patients
Real-time Evaluation of Safety and Efficacy of Convalescent Plasma Units Transfused to Elderly Patients With COVID-19
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- Azienda Socio Sanitaria Territoriale di Mantova · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
The trend of the spread of the COVID-19 pandemic demonstrates in Lombardy, starting from 28.03.2020, a slowdown in the exponential phase of infections and the probable reaching of a plateau phase. However, a marked increase in infections was observed in the so-called "protected structures" such as nursing homes (RSA), both in health staff and in the residents of such facilities. The observed percentage of lethality, according to the more recent data provided by the National Institute of Health, is very high especially among residents. For these reasons, the city Hospital (ASST) of Mantua , already involved in the use of hyperimmune plasma as a therapy for COVID-19, designed this study in order to evaluate RSA patients and to identify the cases eligible for this treatment.
Detailed description
For a detailed description of the study, see the attached protocol
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Convalescent plasma | COVID-19 elderly patients treated with convalescent plasma |
Timeline
- Start date
- 2020-05-15
- Primary completion
- 2020-08-15
- Completion
- 2020-09-03
- First posted
- 2020-09-29
- Last updated
- 2020-10-05
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04569188. Inclusion in this directory is not an endorsement.